Gene-Guided blood thinner strategy may reduce bleeding after stents

NCT ID NCT06588595

Recruiting now Disease control Sponsor: University of Florida Source: ClinicalTrials.gov ↗

First seen Feb 26, 2026 · Last updated May 24, 2026 · Updated 7 times

Summary

This study tests whether using a genetic score (ABCD-GENE) to guide reducing blood thinners after heart stent placement works better than the usual approach. About 90 adults who have had a stent and are on two blood thinners will be randomly assigned to either a gene-guided or standard reduction plan. The goal is to see if the gene-guided method keeps blood clotting under control while potentially lowering bleeding risks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Florida
RECRUITING

Jacksonville, Florida, 32209, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CORONARY ARTERIAL DISEASE (CAD)